We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effect of Guanfacine on Opioid-induced Hyperalgesia (OIH) and Tolerance

This study is currently recruiting participants.
Verified June 2017 by Jianren Mao, MD, PhD, Massachusetts General Hospital
Sponsor:
ClinicalTrials.gov Identifier:
NCT01681264
First Posted: September 7, 2012
Last Update Posted: June 14, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Collaborators:
National Institutes of Health (NIH)
National Institute on Drug Abuse (NIDA)
Information provided by (Responsible Party):
Jianren Mao, MD, PhD, Massachusetts General Hospital
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2018
  Estimated Primary Completion Date: July 2018 (Final data collection date for primary outcome measure)